Novel and alternative therapies for childhood constipation

Current Gastroenterology Reports

Volumn 9, Issue 3, 2007, Pages 214-218

  Liem, Olivia ^a   Benninga, Marc A ^b   Mousa, Hayat M ^b   Di Lorenzo, Carlo ^b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALVIMOPAN; BOTULINUM TOXIN; CHLORIDE CHANNEL; LACTULOSE; LAXATIVE; LUBIPROSTONE; MU OPIATE RECEPTOR; NALOXONE; PLACEBO; PROBIOTIC AGENT; SEROTONIN RECEPTOR; TEGASEROD;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; ADJUVANT THERAPY; BEHAVIOR MODIFICATION; BIFIDOBACTERIUM; CECOSTOMY; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLON LAVAGE; CONSTIPATION; DEFECATION; DEVICE INFECTION; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG TOLERABILITY; ELECTROSTIMULATION; FECES INCONTINENCE; HUMAN; INJECTION PAIN; INTERSTITIAL CYSTITIS; INTESTINE FLORA; LONG TERM CARE; NAUSEA; PATIENT SAFETY; QUALITY OF LIFE; REFLEXOLOGY; REVIEW; SPHINCTEROTOMY; STENOSIS; TRANSCUTANEOUS NERVE STIMULATION; UNSPECIFIED SIDE EFFECT;

ACUPUNCTURE THERAPY; ALPROSTADIL; BOTULINUM TOXINS; CHILD; COMPLEMENTARY THERAPIES; CONSTIPATION; ELECTRIC STIMULATION; FATTY ACIDS; HUMANS; INDOLES; MASSAGE; PIPERIDINES; PROBIOTICS; SEROTONIN AGONISTS;

EID: 34249863322     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0021-4     Document Type: Review

References (48)

1. Molnar D, Taitz LS, Urwin OM, et al.: Anorectal manometry results in defecation disorders. Arch Dis Child 1983, 58:257-261.
2. van den Berg MM, Benninga MA, Di Lorenzo C: Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol 2006, 101:2401-2409.
3. Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2006, 43:e1-e13.
4. Loening-Baucke V: Constipation in children. Curr Opin Pediatr 1994; 6:556-561.
5. van Ginkel R, Reitsma JB, Buller HA, et al.: Childhood constipation: longitudinal follow-up beyond puberty. Gastroenterology 2003; 125:357-363.
6. Van den Berg MM, Van Rossum CH, de Lorijn F, et al.: Functional constipation in infants: a follow-up study. J Pediatr 2005, 147:700-704.
7. Coffin B, Farmachidi JP, Rueegg P, et al.: Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects. Aliment Pharmacol Ther 2003, 17:577-585.
8. Degen L, Petrig C, Studer D, et al.: Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 2005, 17:821-826.
9. Prather CM, Camilleri M, Zinsmeister AR, et al.: Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000, 118:463-468.
10. Rodriguez-Stanley S, Zubaidi S, Proskin HM, et al.: Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity. Clin Gastroenterol Hepatol 2006, 4:442-450.
11. Kellow J, Lee OY, Chang FY, et al.: An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 2003, 52:671-676.
12. Novick J, Miner P, Krause R, et al.: A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002, 16:1877-1888.
13. Kamm MA, Muller-Lissner S, Talley NJ, et al.: Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005, 100:362-372.
14. Khoshoo V, Armstead C, Landry L: Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome. Aliment Pharmacol Ther 2006, 23:191-196.
15. Furlano R, Sidler MA, Beglinger C. Tegaserod: A prokinetic agent for the treatment of chronic functional constipation in children? [abstract] J Pediatr Gastroenterol Nutr 2004, 39:S233.
16. Camilleri M, Bharucha AE, Ueno R, et al.: Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2006, 290:G942-G947.
17. Johanson JF, Gargano MA, Patchen ML, et al.: Efficacy and safety of a novel compound, RU-0211, for the treatment of constipation [abstract]. Gastroenterology 2002, 122:A-315.
18. Johanson JF, Gargano MA, Patchen ML, et al.: Phase III study of lubiprostone, a chloride channel-2 (CIC-2) activator for treatment of constipation: safety and primary efficacy. [abstract]. Am J Gastroenterol 2005, 100:S328.
19. Roy S, Liu HC, Loh HH: mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit. Brain Res Mol Brain Res 1998, 56:281-283.
20. Tofil NM, Benner KW, Faro SJ, et al.: The use of enteral naloxone to treat opioid-induced constipation in a pediatric intensive care unit. Pediatr Crit Care Med. 2006, 7:252-254.
21. Szajewska H, Ruszczynski M, Radzikowski A: Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006, 149:367-372.
22. Marteau P, Cuillerier E, Meance S, et al.: Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002, 16:587-593.
23. Koebnick C, Wagner I, Leitzmann P, et al.: Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003, 17:655-659.
24. Banaszkiewicz A, Szajewska H: Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J Pediatr 2005, 146:364-369.
25. Salminen S, Salminen E: Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol 1997, 222(Suppl):45-48.
26. Foligne B, Grangette C, Pot B: Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects. Gut 2005, 54:727-728.
27. Abrams P, Blaivas JG, Fowler CJ, et al.: The role of neuromodulation in the management of urinary urge incontinence. BJU Int 2003, 91:355-359.
28. Humphreys MR, Vandersteen DR, Slezak JM, et al.: Preliminary results of sacral neuromodulation in 23 children. J Urol 2006, 176:2227-2231.
29. Bernstein AJ, Peters KM: Expanding indications for neuromodulation. Urol Clin North Am 2005, 32:59-63.
30. Jarrett ME, Mowatt G, Glazener CM, et al.: Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg 2004, 91:1559-1569.
31. Malouf AJ, Wiesel PH, Nicholls T, et al.: Short-term effects of sacral nerve stimulation for idiopathic slow transit constipation. World J Surg 2002, 26:166-170.
32. Kenefick NJ, Vaizey CJ, Cohen CR, et al.: Double-blind placebo-controlled crossover study of sacral nerve stimulation for idiopathic constipation. Br J Surg 2002, 89:1570-1571.
33. Chase J, Robertson VJ, Southwell B, et al.: Pilot study using transcutaneous electrical stimulation (interferential current) to treat chronic treatment-resistant constipation and soiling in children. J Gastroenterol Hepatol 2005, 20:1054-1061.
34. Campbell A: The origins of acupuncture. Acupunct Med 2002, 20:141.
35. Broide E, Pintov S, Portnoy S, et al.: Effectiveness of acupuncture for treatment of childhood constipation. Dig Dis Sci 2001, 46:1270-1275.
36. Klauser AG, Rubach A, Bertsche O, et al.: Body acupuncture: effect on colonic function in chronic constipation. Z Gastroenterol 1993, 31:605-608.
37. Hall N: Reflexology. London: Thorsons; 1996.
38. Bishop E, McKinnon E, Weir E, et al.: Reflexology in the management of encopresis and chronic constipation. Paediatr Nurs 2003, 15:20-21.
39. Klauser AG, Flaschentrager J, Gehrke A, et al.: Abdominal wall massage: effect on colonic function in healthy volunteers and in patients with chronic constipation. Z Gastroenterol 1992, 30:247-251.
40. Ciamarra P, Nurko S, Barksdale E, et al.: Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin. J Pediatr Gastroenterol Nutr 2003, 37: 315-319.
41. Langer JC, Birnbaum E: Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease. J Pediatr Surg 1997, 32:1059-1061.
42. Youssef NN, Langseder AL, Verga BJ, et al.: Chronic childhood constipation is associated with impaired quality of life: a case-controlled study. J Pediatr Gastroenterol Nutr 2005, 41:56-60.
43. Mousa HM, van den Berg MM, Caniano DA, et al.: Cecostomy in children with defecation disorders. Dig Dis Sci 2006, 51:154-160.
44. Rivera MT, Kugathasan S, Berger W, et al.: Percutaneous colonoscopic cecostomy for management of chronic constipation in children. Gastrointest Endosc 2001, 53:225-228.
45. Youssef NN, Barksdale JE, Griffiths JM, et al.: Management of intractable constipation with antegrade enemas in neurologically intact children. J Pediatr Gastroenterol Nutr 2002, 34:402-405.
46. van den Berg MM, Hogan M, Caniano DA, et al.: Colonic manometry as predictor of cecostomy success in children with defecation disorders. J Pediatr Surg 2006, 4:730-736.
47. Griffiths DM, Malone PS: The Malone antegrade continence enema. J Pediatr Surg 1995, 30:68-71.
48. Cascio S, Flett ME, De La HM, et al.: MACE or caecostomy button for idiopathic constipation in children: a comparison of complications and outcomes. Pediatr Surg Int 2004, 20:484-487.